Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Dividend Stock Portfolio: Top 5 Stocks to Buy According to Reddit

In this article, we will take a look at the Dividend Stock Portfolio: Top 5 Stocks to Buy According to Reddit. For deeper discussion and analysis, read Dividend Stock Portfolio: Top 10 Stocks to Buy According to Reddit.

5. Honeywell International Inc. (NASDAQ:HON)

Number of Hedge Fund Holders: 75

On June 15, Honeywell International Inc. (NASDAQ:HON) announced that its Board of Directors had officially approved the planned spin-off of Honeywell Aerospace. The decision marks a major milestone in the separation process, which remains on track to be completed on June 29, 2026. Once the transaction is finalized, the remaining automation-focused business will operate under the name Honeywell Technologies.

Honeywell Aerospace common stock is expected to begin trading on the Nasdaq Stock Market under the ticker symbol “HONAV” on a “when-issued” basis on or about June 15, 2026.

The company expects Honeywell Aerospace shares to begin “regular-way” trading on Nasdaq under the ticker symbol “HONA” on June 29, 2026. After the separation is completed, Honeywell Technologies will continue to trade on Nasdaq under the ticker symbol “HON.”

Honeywell International Inc. (NASDAQ:HON) operates across a broad range of industries and geographic markets worldwide. Its portfolio is supported by the Honeywell Accelerator operating system and the Honeywell Forge platform, which help drive the company’s operations and technology offerings.

4. Walmart Inc. (NASDAQ:WMT)

Number of Hedge Fund Holders: 99

On June 15, Reuters reported that China’s market regulator had ordered Walmart Inc. (NASDAQ:WMT)-owned Sam’s Club to take strict measures across its supply chain to address food safety risks and protect public food safety. The move comes as Sam’s Club continues to expand in China. According to the company’s website, the membership-only retail chain recorded double-digit growth in transactions last year, supported by new store openings that increased its nationwide store count to 63.

The regulator’s action followed a meeting with a Sam’s Club executive to discuss recently identified food safety issues. In a notice released on June 15, the State Administration for Market Regulation said the meeting had taken place but did not disclose the date.

Walmart’s China office did not immediately respond to a request for comment.

“We will regularly report rectification progress to the regulatory authorities and proactively accept supervision,” Sam’s Club said in an apology cited by state-backed media outlet The Paper. The company also said it had established a special task force led by senior management to address the issues. The effort includes supply chain inspections and measures aimed at strengthening compliance with regulations and maintaining product quality standards.

Walmart Inc. (NASDAQ:WMT) is a technology-powered omnichannel retailer that operates retail and wholesale stores, membership clubs, e-commerce websites, and mobile applications. The company has operations across the United States, Africa, Canada, Central America, Chile, China, India, and Mexico.

3. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 113

On May 31, Reuters reported that Johnson & Johnson (NYSE:JNJ)’s prostate cancer drug Erleada, when used alongside hormone-blocking therapy for six months before and after prostate surgery, improved the chances of eliminating cancer and lowered the risk of disease progression or death, according to data from a late-stage clinical trial.

The study followed patients for more than five years. Researchers found that patients who received the combination treatment were nine times more likely to have little to no detectable cancer in the prostate at the time of surgery compared with those who received testosterone-blocking therapy alone.

Johnson & Johnson said the addition of Erleada also reduced the risk of cancer spreading or death by 20%. The findings were presented at the American Society of Clinical Oncology meeting in Chicago and could influence how doctors treat men with high-risk localized or locally advanced prostate cancer. Surgery to remove the prostate and radiation therapy are currently the standard treatments for these patients.

According to Johnson & Johnson, about 40% of the 330,000 people diagnosed with prostate cancer each year in the United States are considered high-risk. The trial also evaluated a full year of treatment with Erleada and hormone therapy before and after surgery. Among those patients, men who received the combination treatment went more than six years on average before needing additional treatment. That was nearly twice as long as the time for patients who received hormone therapy alone. The longer Erleada treatment regimen also reduced the risk of recurrence and death by 29%.

Johnson & Johnson (NYSE:JNJ) and its subsidiaries are engaged in the research, development, manufacture, and sale of healthcare products. The company operates through its Innovative Medicine and MedTech segments.

2. JPMorgan Chase & Co. (NYSE:JPM)

Number of Hedge Fund Holders: 131

A June 17 report from the Financial Times said JPMorgan Chase & Co. (NYSE:JPM) is aiming to expand its digital bank into at least five European countries over the next five years. The step came as the bank looks to grow its retail banking presence across the region. People familiar with the matter said the bank plans to add at least three more countries to its existing operations in the UK and Germany by the end of 2030. France, Spain, and Italy are among the markets being considered, though executives have not yet decided which country will be next.

JPMorgan launched Chase in the UK in 2021, marking the first step in CEO Jamie Dimon’s plan to take the bank’s retail business beyond the United States. The company entered Germany last month, its first retail banking expansion into continental Europe.

While JPMorgan has built a massive deposit base of $2.6 trillion in the US, expanding across Europe brings a different set of challenges. The region has a more fragmented banking landscape, with varying regulatory requirements and strong local competitors. Bank executives believe they can navigate those obstacles and move more quickly than they did in the past, after a five-year gap separated the launches of its UK and German retail banking operations.

JPMorgan Chase & Co. (NYSE:JPM) is a financial holding company that provides investment banking, commercial banking, asset management, financial transaction processing, and financial services for consumers and small businesses.

1. Advanced Micro Devices, Inc. (NASDAQ:AMD)

Number of Hedge Fund Holders: 134

On June 17, Bernstein raised its price recommendation on Advanced Micro Devices, Inc. (NASDAQ:AMD) to $600 from $525. It reiterated an Outperform rating on the stock. The firm expects AMD to benefit from stronger demand in the server market. Bernstein noted that its existing model for the company already reflected a healthier server CPU environment, resulting in only modest changes to its estimates.

A few days earlier, on June 12, Citi upgraded AMD to Buy from Neutral and increased its price target to $575 from $460.Analyst Atif Malik said the market is not fully recognizing the upside potential of AMD’s graphics processing unit business. In a research note, he described AMD as “emerging as a legit second source” in the GPU market. Citi believes the company is well-positioned to capture the “lion’s share” of opportunities at Meta. The firm also argued that investors continue to view AMD primarily as a central processing unit company, which it believes leaves room for further upside in the stock.

Advanced Micro Devices, Inc. (NASDAQ:AMD) is a global semiconductor company focused on high-performance computing and artificial intelligence (AI). The company operates through its Data Center, Client and Gaming, and Embedded segments.

While we acknowledge the potential of AMD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than AMD and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 12 Stocks From Companies Generating High Cash Flow and 12 Stocks with Highest Dividend to Invest In Now

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.